التفاصيل البيبلوغرافية
| العنوان: |
Singapore tuberculosis (TB) clinical management guidelines 2024: A modified Delphi adaptation of international guidelines for drug-susceptible TB infection and pulmonary disease. |
| المؤلفون: |
Teng, Ang Michelle Lay, Chan Si Min, Cheng Lionel Tim-Ee, Cheong Hau Yiang, Chew Ka Lip, Maciej, Chlebicki Piotr, Hsu Li Yang, Kaw Gregory Jon Leng, Kee Adrian Chin Leong, Ng Mark Chung Wai, Ong Rick Twee Hee, Ong Catherine Wei Min, Lishan, Quah Jessica, D/O Balasubramaniam, Selvamani, Sng Li Hwei, Tan Jamie Bee Xian, Tan Cher Heng, Tay Jun Yang, Teo Lynette Li San, Thoon Koh Cheng |
| المصدر: |
Annals of the Academy of Medicine, Singapore; Mar2024, Vol. 53 Issue 3, p170-186, 17p |
| مصطلحات موضوعية: |
LUNG diseases, TUBERCULOSIS, LUNG infections, LITERATURE reviews, MEDICAL screening, SHORT bowel syndrome, MUCOSITIS |
| مصطلحات جغرافية: |
SINGAPORE |
| مستخلص: |
Introduction: Tuberculosis (TB) remains endemic in Singapore. Singapore's clinical practice guidelines for the management of tuberculosis were first published in 2016. Since then, there have been major new advances in the clinical management of TB, ranging from diagnostics to new drugs and treatment regimens. The National TB Programme convened a multidisciplinary panel to update guidelines for the clinical management of drug-susceptible TB infection and disease in Singapore, contextualising current evidence for local practice. Method: Following the ADAPTE framework, the panel systematically reviewed, scored and synthesised English-language national and international TB clinical guidelines published from 2016, adapting recommendations for a prioritised list of clinical decisions. For questions related to more recent advances, an additional primary literature review was conducted via a targeted search approach. A 2-round modified Delphi process was implemented to achieve consensus for each recommendation, with a final round of edits after consultation with external stakeholders. Results: Recommendations for 25 clinical questions spanning screening, diagnosis, selection of drug regimen, monitoring and follow-up of TB infection and disease were formulated. The availability of results from recent clinical trials led to the inclusion of shorter treatment regimens for TB infection and disease, as well as consensus positions on the role of newer technologies, such as computer-aided detectionartificial intelligence products for radiological screening of TB disease, next-generation sequencing for drugsusceptibility testing, and video observation of treatment. Conclusion: The panel updated recommendations on the management of drug-susceptible TB infection and disease in Singapore. [ABSTRACT FROM AUTHOR] |
|
Copyright of Annals of the Academy of Medicine, Singapore is the property of Academy of Medicine Singapore and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder